Helix Acquisition Corp. II, a special purpose acquisition company (SPAC) incorporated on June 15, 2021, reported its financial results for the period ending September 30, 2024. The company, which focuses on the healthcare and healthcare-related industries, completed its Initial Public Offering (IPO) on February 13, 2024, selling 18,400,000 Class A ordinary shares at $10.00 each, generating gross proceeds of $184 million. Additionally, the Sponsor purchased 509,000 Private Placement Shares for $5.09 million. After accounting for transaction costs of $8.18 million, the net proceeds of $186.5 million were placed in a Trust Account.
As of September 30, 2024, Helix Acquisition Corp. II reported total assets of $192.3 million, with $190.2 million held in marketable securities, primarily U.S. Treasury Bills. The company had cash of $1.79 million, a significant increase from $0 at the end of 2023. Total current liabilities stood at $126,690, while total liabilities were $5.65 million, resulting in a shareholders’ deficit of $(3.52 million).
For the three months ended September 30, 2024, Helix reported a net income of $2.33 million, with basic net income per share of $0.10 for both Class A and Class B ordinary shares. This performance was supported by interest income from marketable securities amounting to $2.55 million. For the nine months ended September 30, 2024, the net income totaled $5.65 million, reflecting a substantial increase compared to the same period in 2023, when the company reported no income.
General and administrative expenses for the three months were $146,852, and for the nine months, they totaled $365,896. The company also incurred share-based compensation expenses of $77,400 for the quarter and $194,172 for the nine months.
As of September 30, 2024, Helix had 18,909,000 Class A ordinary shares and 4,600,000 Class B ordinary shares issued and outstanding. The company has established a completion window of 24 months from the IPO to finalize a Business Combination, or it will liquidate and redeem public shares at the amount in the Trust Account.
Overall, Helix Acquisition Corp. II's financial position has improved significantly since its IPO, with a strong cash position and positive net income, positioning the company for potential future acquisitions in the healthcare sector.
About Helix Acquisition Corp. II
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.